NCT07225283
Developing Resiliency and Exercise Using AI-based Messaging
Not Yet Recruiting
NAAll AgesInterventionalPreventionMassachusetts General HospitalInvestigator-initiated
~20 participants
Updated 2026-05-18 on ClinicalTrials.gov
What's tested:DREAM
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Delivery of messaging sessions (feasibility)
Measured over Twice weekly over 8 weeks
Conditions
Where it's being run
1 sites across 1 statesMassachusetts1
Study leadership
- Christopher M Celano, M.D. · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Type 2 diabetes diagnosis (A1c ≥6.5%, fasting glucose ≥126 mg/dL)
Suboptimal physical activity (score \< 5 on the Medical Outcomes Study Specific Adherence Scale physical activity item)
Access to a smartphone (i.e., Android or iOS) or computer with access to the internet and an internet browser
Exclusion
An unrelated condition limiting physical activity
Participation in any other programs focused on physical activity or well-being
A cognitive disturbance precluding participation or informed consent
Current pregnancy or plan to become pregnant in the next 16 weeks
Inability to speak/write fluently in English
Use of non-basal insulin
What this trial measures
- Delivery of messaging sessions (feasibility)Twice weekly over 8 weeks
Proportion of messaging sessions successfully initiated